|
Razadyne ErDrug - Razadyne Er The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Galantamine Hydrobromide
Strength -
EQ 8MG BASE
Applicant -
JANSSEN
New Drug Application (NDA) Number -
021615
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 22, 2004
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Janssen Pharmaceutica Inc
Razadyne Er
Razadyne Er Eq 8mg Base Capsule, Extended Release; Oral
Magnevist 469.01mg/ml Injectable; Injection Magnevist 469.01mg/ml Injectable; Injection Prohance 279.3mg/ml Injectable; Injection Prohance Multipack 279.3mg/ml Injectable; Injection Optimark 330.9mg/ml Injectable; Injection Optimark 330.9mg/ml Injectable; Injection Optimark In Plastic Container 330.9mg/ml Injectable; Injection Razadyne Er Eq 16mg Base Capsule, Extended Release; Oral Razadyne Er Eq 24mg Base Capsule, Extended Release; Oral NewDrugInformation |